Jaiparka tablets 100mg

Jaiparka tablets 100mg, from Eli Lilly Japan, contains Pirtobrutinib (YJ code: 4291084F2023, standard: 100mg 1 tablet). This non-covalent BTK inhibitor offers a new treatment approach for B-cell malignancies, especially for patients resistant to earlier BTK inhibitors. It works by inhibiting BTK activity in the B-cell receptor pathway, crucial for B-cell proliferation and survival.